During the past decade, Southeast Alabama Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeast Alabama Medical Center" are "Atrial Fibrillation New Onset" (1 trials), "Complicated Urinary Tract Infection" (1 trials) and "Intracranial Aneurysm" (1 trials). Many other conditions were trialed in "Southeast Alabama Medical Center" in a lesser frequency.

Most popular intervention types in "Southeast Alabama Medical Center" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CorMatrix ECM for Pericardial Closure" (1 trials), "Imipenem/Cilastatin" (1 trials), "NXL104/ceftazidime" (1 trials), "Penumbra Coil 400TM (PC400), Penumbra Occlusion DeviceTM(POD)" (1 trials) and "Penumbra Smart Coil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Alabama Medical Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Southeast Alabama Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Southeast Alabama Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Alabama Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".